BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Paumgartner G. Medical treatment of cholestatic liver diseases: From pathobiology to pharmacological targets. World J Gastroenterol 2006; 12(28): 4445-4451 [PMID: 16874853 DOI: 10.3748/wjg.v12.i28.4445]
URL: https://www.wjgnet.com/1007-9327/full/v12/i28/4445.htm
Number Citing Articles
1
Edna Strauss. Palliative Medicine2009; : 459 doi: 10.1016/B978-0-323-05674-8.50088-8
2
Elemér Nemesánszky. Unfavourable laboratory results and hepatic disorders in pregnancy: causes and consequencesOrvosi Hetilap 2013; 154(29): 1135 doi: 10.1556/OH.2013.29635
3
Tomofumi Fujino, Kaori Murakami, Issei Ozawa, Yoshie Minegishi, Ryo Kashimura, Toshihiro Akita, Susumu Saitou, Takehisa Atsumi, Takashi Sato, Ken Ando, Shuntaro Hara, Kiyomi Kikugawa, Makio Hayakawa. Hypoxia downregulates farnesoid X receptor via a hypoxia‐inducible factor‐independent but p38 mitogen‐activated protein kinase‐dependent pathwayThe FEBS Journal 2009; 276(5): 1319 doi: 10.1111/j.1742-4658.2009.06867.x
4
Sevtap Aydın, Mehmet Tokaç, Gökçe Taner, Ata Türker Arıkök, Halit Ziya Dündar, Alper Bilal Özkardeş, Mine Yavuz Taşlıpınar, Mehmet Kılıç, Arif Ahmet Başaran, Nurşen Başaran. Antioxidant and antigenotoxic effects of lycopene in obstructive jaundiceJournal of Surgical Research 2013; 182(2): 285 doi: 10.1016/j.jss.2012.10.031
5
Ulrich Beuers, Gerd A. Kullak-Ublick, Thomas Pusl, Erik R. Rauws, Christian Rust. Medical Treatment of Primary Sclerosing Cholangitis: A Role for Novel Bile Acids and other (post-)Transcriptional Modulators?Clinical Reviews in Allergy & Immunology 2009; 36(1): 52 doi: 10.1007/s12016-008-8085-y
6
Dirk R. de Waart, Stephanie Häusler, Maria L. H. Vlaming, Cindy Kunne, Emanuel Hänggi, Hans-Jurgen Gruss, Ronald P. J. Oude Elferink, Bruno Stieger. Hepatic Transport Mechanisms of Cholyl-l-Lysyl-FluoresceinJournal of Pharmacology and Experimental Therapeutics 2010; 334(1): 78 doi: 10.1124/jpet.110.166991
7
Duohu Wu, Chuanyu Bao, Longhe Li, Mingliang Fu, Desen Wang, Jinyuan Xie, Xiaoguang Gong. Chlorogenic acid protects against cholestatic liver injury in ratsJournal of Pharmacological Sciences 2015; 129(3): 177 doi: 10.1016/j.jphs.2015.10.005
8
T.D. Zvyagintseva, I.I. Shargorod. Chronic acalculous cholecystitis: clinical features, diagnosis and treatment.Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini 2015; 2015(2): 13 doi: 10.15407/internalmed2015.02.013
9
Mei Lan Chen, Kiyoshi Takeda, Mark S. Sundrud. Emerging roles of bile acids in mucosal immunity and inflammationMucosal Immunology 2019; 12(4): 851 doi: 10.1038/s41385-019-0162-4
10
Stephan von Haehling, Joerg C. Schefold, Ewa A. Jankowska, Jochen Springer, Ali Vazir, Paul R. Kalra, Anja Sandek, Günter Fauler, Tatjana Stojakovic, Michael Trauner, Piotr Ponikowski, Hans-Dieter Volk, Wolfram Doehner, Andrew J.S. Coats, Philip A. Poole-Wilson, Stefan D. Anker. Ursodeoxycholic Acid in Patients With Chronic Heart FailureJournal of the American College of Cardiology 2012; 59(6): 585 doi: 10.1016/j.jacc.2011.10.880
11
Cen Guo, Lei He, Dan Yao, Jiye A, Bei Cao, Jin Ren, Guangji Wang, Guoyu Pan. Alpha-naphthylisothiocyanate modulates hepatobiliary transporters in sandwich-cultured rat hepatocytesToxicology Letters 2014; 224(1): 93 doi: 10.1016/j.toxlet.2013.09.019
12
Enver Reyhan, Mustafa Duman, Yeliz Demirci, Ali Emre Atici, Mahmut Ozer, Burcu Cevreli, Feza Ekiz, Tahsin Dalgic, Musa Akoglu, Ece Genc. Superiority of Ceftriaxon to Cefazolin in a Rat Model of Obstructive Jaundice: An Experimental StudyJournal of Investigative Surgery 2013; 26(1): 11 doi: 10.3109/08941939.2012.687433
13
T. E. Polunina. Cholestasis: algorithms for diagnosis and treatmentAcademy of medicine and sports 2022; 2(4): 28 doi: 10.15829/2712-7567-2021-43
14
E. Fernández-Martínez. Liver Pathophysiology2017; : 239 doi: 10.1016/B978-0-12-804274-8.00018-7
15
Nobuyuki Tamaki, Etsuro Hatano, Kojiro Taura, Masaharu Tada, Yuzo Kodama, Takashi Nitta, Keiko Iwaisako, Satoru Seo, Akio Nakajima, Iwao Ikai, Shinji Uemoto. CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injuryAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2008; 294(2): G498 doi: 10.1152/ajpgi.00482.2007
16
James L. Boyer. New perspectives for the treatment of cholestasis: Lessons from basic science applied clinicallyJournal of Hepatology 2007; 46(3): 365 doi: 10.1016/j.jhep.2006.12.001
17
Cynthia R.L. Webster, Johanna Cooper. Therapeutic Use of Cytoprotective Agents in Canine and Feline Hepatobiliary DiseaseVeterinary Clinics of North America: Small Animal Practice 2009; 39(3): 631 doi: 10.1016/j.cvsm.2009.02.002
18
Jean-Michel Vandeweerd, Carole Cambier, Pascal Gustin. Nutraceuticals for Canine Liver DiseaseVeterinary Clinics of North America: Small Animal Practice 2013; 43(5): 1171 doi: 10.1016/j.cvsm.2013.05.003
19
Tingting Yang, Huifang Mei, Dengqiu Xu, Wang Zhou, Xiaoyu Zhu, Lixin Sun, Xin Huang, Xue Wang, Ting Shu, Jia Liu, Jiaxin Ding, H.M. Hassan, Luyong Zhang, Zhenzhou Jiang. Early indications of ANIT-induced cholestatic liver injury: Alteration of hepatocyte polarization and bile acid homeostasisFood and Chemical Toxicology 2017; 110: 1 doi: 10.1016/j.fct.2017.09.051
20
Soyeon An, Eungyeong Jang, Jang-Hoon Lee, Sokcheon Pak. Preclinical Evidence of Curcuma longa and Its Noncurcuminoid Constituents against Hepatobiliary Diseases: A ReviewEvidence-Based Complementary and Alternative Medicine 2020; 2020(1) doi: 10.1155/2020/8761435
21
Naoki Tanimizu, Atsushi Miyajima, Keith E. Mostov, Asma Nusrat. Liver Progenitor Cells Fold Up a Cell Monolayer into a Double-layered Structure during Tubular MorphogenesisMolecular Biology of the Cell 2009; 20(9): 2486 doi: 10.1091/mbc.e08-02-0177
22
Jennifer M. Longpre, George Loo. Protection of human colon epithelial cells against deoxycholate by rottlerinApoptosis 2008; 13(9): 1162 doi: 10.1007/s10495-008-0244-3
23
Huanhuan Yu, Lulu Zhang, Pei Chen, Xiaofang Liang, Aizhi Cao, Juan Han, Xiufeng Wu, Yinhua Zheng, Yuchang Qin, Min Xue. Dietary Bile Acids Enhance Growth, and Alleviate Hepatic Fibrosis Induced by a High Starch Diet via AKT/FOXO1 and cAMP/AMPK/SREBP1 Pathway in Micropterus salmoidesFrontiers in Physiology 2019; 10 doi: 10.3389/fphys.2019.01430
24
Omkar B. Ijare, Tedros Bezabeh, Nils Albiin, Urban Arnelo, Annika Bergquist, Bo Lindberg, Ian C.P. Smith. Absence of glycochenodeoxycholic acid (GCDCA) in human bile is an indication of cholestasis: A 1H MRS studyNMR in Biomedicine 2009; 22(5): 471 doi: 10.1002/nbm.1355
25
Mehmet Tokaç, Gökçe Taner, Sevtap Aydın, Alper Bilal Özkardeş, Halit Ziya Dündar, Mine Yavuz Taşlıpınar, Ata Türker Arıkök, Mehmet Kılıç, Arif Ahmet Başaran, Nursen Basaran. Protective effects of curcumin against oxidative stress parameters and DNA damage in the livers and kidneys of rats with biliary obstructionFood and Chemical Toxicology 2013; 61: 28 doi: 10.1016/j.fct.2013.01.015
26
Yanpeng Zhang, Hexiong Feng, Xu-Fang Liang, Shan He, Jie Lan, Ling Li. Dietary bile acids reduce liver lipid deposition via activating farnesoid X receptor, and improve gut health by regulating gut microbiota in Chinese perch (Siniperca chuatsi)Fish & Shellfish Immunology 2022; 121: 265 doi: 10.1016/j.fsi.2022.01.010
27
Olga Martínez-Augustin, Fermín Sánchez de Medina. Intestinal bile acid physiology and pathophysiologyWorld Journal of Gastroenterology 2008; 14(37): 5630-5640 doi: 10.3748/wjg.14.5630
28
Gustav PAUMGARTNER. Pharmacotherapy of cholestatic liver diseasesJournal of Digestive Diseases 2010; 11(3): 119 doi: 10.1111/j.1751-2980.2010.00427.x
29
Gustav Paumgartner, Thomas Pusl. Medical Treatment of Cholestatic Liver DiseaseClinics in Liver Disease 2008; 12(1): 53 doi: 10.1016/j.cld.2007.11.013
30
Gustav Paumgartner. Biliary physiology and diseaseHepatology 2010; 51(4): 1095 doi: 10.1002/hep.23472
31
Julia Waizenegger, Josephin Glück, Marcus Henricsson, Claudia Luckert, Albert Braeuning, Stefanie Hessel-Pras. Pyrrolizidine Alkaloids Disturb Bile Acid Homeostasis in the Human Hepatoma Cell Line HepaRGFoods 2021; 10(1): 161 doi: 10.3390/foods10010161
32
Katryn Allen, Nam Deuk Kim, Jeon-OK Moon, Bryan L. Copple. Upregulation of early growth response factor-1 by bile acids requires mitogen-activated protein kinase signalingToxicology and Applied Pharmacology 2010; 243(1): 63 doi: 10.1016/j.taap.2009.11.013
33
Tanaporn Khamphaya, Piyachat Chansela, Pawinee Piyachaturawat, Apichart Suksamrarn, Michael H. Nathanson, Jittima Weerachayaphorn. Effects of andrographolide on intrahepatic cholestasis induced by alpha-naphthylisothiocyanate in ratsEuropean Journal of Pharmacology 2016; 789: 254 doi: 10.1016/j.ejphar.2016.07.032
34
R. G. MYAZIN. THE ROLE OF URSODEOXYCHOLIC ACID IN THE TREATMENT OF CHRONIC VIRAL HEPATITISMedical Council 2017; (4): 31 doi: 10.21518/2079-701X-2017-4-31-35
35
Ruicong Sun, Chunjin Xu, Baisui Feng, Xiang Gao, Zhanju Liu. Critical roles of bile acids in regulating intestinal mucosal immune responsesTherapeutic Advances in Gastroenterology 2021; 14 doi: 10.1177/17562848211018098
36
S. Stahl, M. R. Davies, D. I. Cook, M. J. Graham. Nuclear hormone receptor-dependent regulation of hepatic transporters and their role in the adaptive response in cholestasisXenobiotica 2008; 38(7-8): 725 doi: 10.1080/00498250802105593
37
Debashree Debasish Das, Nikita Sharma, Pooja A Chawla. Current trends and future perspectives in the treatment of PBC and PSC: A reviewHealth Sciences Review 2022; 5: 100065 doi: 10.1016/j.hsr.2022.100065
38
V. Šmíd, T. Petr, K. Váňová, J. Jašprová, J. Šuk, L. Vítek, F. Šmíd, Lucie Muchová. Changes in Liver Ganglioside Metabolism in Obstructive Cholestasis – the Role of Oxidative StressFolia Biologica 2016; 62(4): 148 doi: 10.14712/fb2016062040148
39
Somayeh Baghbaderani, Mohammad Nasehi, Mehrdad Hashemi. The expression studies of Bcl-xl gene subsequent effect of cholestasis and treatment by curcumin in hippocampus of male rats MEDICAL SCIENCES JOURNAL 2018; 28(1): 37 doi: 10.29252/iau.28.1.37
40
Hanns-Ulrich Marschall, Martin Wagner, Gernot Zollner, Michael Trauner. Clinical Hepatotoxicity. Regulation and Treatment with Inducers of Transport and CofactorsMolecular Pharmaceutics 2007; 4(6): 895 doi: 10.1021/mp060133c
41
Qiao-ling Yang, Fan Yang, Jun-ting Gong, Xiao-wen Tang, Guang-yun Wang, Zheng-tao Wang, Li Yang. Sweroside ameliorates α-naphthylisothiocyanate-induced cholestatic liver injury in mice by regulating bile acids and suppressing pro-inflammatory responsesActa Pharmacologica Sinica 2016; 37(9): 1218 doi: 10.1038/aps.2016.86
42
Azza S. Awad, Rehab Kamel. Effect of rosuvastatin on cholestasis‐induced hepatic injury in rat liversJournal of Biochemical and Molecular Toxicology 2010; 24(2): 89 doi: 10.1002/jbt.20315
43
Gaia Schiavon, Karel Eechoute, Ron H. J. Mathijssen, Peter de Bruijn, Jessica M. van der Bol, Jaap Verweij, Stefan Sleijfer, Walter J. Loos. Biliary Excretion of Imatinib and Its Active Metabolite CGP74588 During Severe Hepatic DysfunctionThe Journal of Clinical Pharmacology 2012; 52(7): 1115 doi: 10.1177/0091270011409235